Kazia Therapeutics (KZIA) Curent Deferred Tax Liability (2016 - 2017)
Kazia Therapeutics (KZIA) posted Curent Deferred Tax Liability of -$110538.5 for Q4 2017, down 126.57% on a QoQ basis from -$48788.1 in Q4 2016, and down 126.57% year-over-year from $416045.6 in Q4 2016.
Kazia Therapeutics (KZIA) has 2 years of Curent Deferred Tax Liability data on file, last reported at -$110538.5 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -110,538.53 |
| Dec 31, 2017 | -110,538.53 |
| Dec 31, 2016 | -48,788.05 |
| Dec 31, 2016 | -48,788.05 |